The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2014

Filed:

Mar. 30, 2010
Applicants:

Riccardo Giovannini, Verona, IT;

Cornelia Dorner-ciossek, Warthausen, DE;

Christian Eickmeier, Mittelbiberach, DE;

Dennis Fiegen, Biberach, DE;

Thomas Fox, Biberach, DE;

Klaus Fuchs, Mittelbiberach, DE;

Niklas Heine, Biberach, DE;

Holger Rosenbrock, Mittelbiberach, DE;

Gerhard Schaenzle, Biberach, DE;

Inventors:

Riccardo Giovannini, Verona, IT;

Cornelia Dorner-Ciossek, Warthausen, DE;

Christian Eickmeier, Mittelbiberach, DE;

Dennis Fiegen, Biberach, DE;

Thomas Fox, Biberach, DE;

Klaus Fuchs, Mittelbiberach, DE;

Niklas Heine, Biberach, DE;

Holger Rosenbrock, Mittelbiberach, DE;

Gerhard Schaenzle, Biberach, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to novel 1,6-disubstituted pyrazolopyrimidinones of formula (I), in which Hc is a tetrahydropyranyl-group and Ris the group V−W−*, whereby V and W independently of each other may be an aryl group or an heteroaryl group, which independently of each other may optionally be substituted. According to one aspect of the invention the new compounds are for use as medicaments or for the manufacture of medicaments, in particular medicaments for the treatment of conditions concerning deficits in perception, concentration, learning or memory. The new compounds are also for the manufacture of medicaments and/or for use in the treatment of e.g. Alzheimer's disease, in particular for cognitive impairment associated with Alzheimer's disease.


Find Patent Forward Citations

Loading…